Extensive alterations of blood metabolites in pediatric cerebral malaria

PLoS ONE

Volumn 12, Issue 4, 2017, Pages

  Gupta, Sanchit ^a   Seydel, Karl ^b,c   Miranda Roman, Miguel A ^a   Feintuch, Catherine M ^a   Saidi, Alex ^b   Kim, Ryung S ^a   Birbeck, Gretchen L ^d   Taylor, Terrie ^b,c   Daily, Johanna P ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MALAWI   (Malawi)

^c MICHIGAN STATE UNIVERSITY   (United States)

^d UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYLIMIDAZOLEACETIC ACID; ARACHIDONIC ACID; ARGININE; DIMETHYLARGININE; GLUTAMIC ACID; GLUTAMINE; IMIDAZOLEACETIC ACID; INDOLEPROPIONIC ACID; KYNURENIC ACID; UNCLASSIFIED DRUG;

AMINO ACID BLOOD LEVEL; ARTICLE; CEREBRAL MALARIA; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; FEMALE; HUMAN; LIMIT OF QUANTITATION; MALAWIAN; MALE; MASS FRAGMENTOGRAPHY; MEASUREMENT ACCURACY; METABOLOMICS; MOLECULAR LIBRARY; MORTALITY; PATHOPHYSIOLOGY; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; BLOOD; COHORT ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFANT; MALARIA FALCIPARUM; MALAWI; PRESCHOOL CHILD;

CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COHORT STUDIES; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; INFANT; MALARIA, CEREBRAL; MALARIA, FALCIPARUM; MALAWI; MALE; TANDEM MASS SPECTROMETRY;

EID: 85018523215     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0175686     Document Type: Article

References (42)

1. WHO. World Malaria Report. Geneva, Switzerland: World Health Organization. 2015.
2. Birbeck GL, Molyneux ME, Kaplan PW, Seydel KB, Chimalizeni YF, Kawaza K, et al. Blantyre Malaria Project Epilepsy Study (BMPES) of neurological outcomes in retinopathy-positive paediatric cerebral malaria survivors: A prospective cohort study. The Lancet Neurology. 2010; 9(12):1173-81. Epub 2010/11/09. PubMed Central PMCID: PMC2988225. https://doi.org/10.1016/S1474-4422(10)70270-2 PMID: 21056005.
3. Idro R, Marsh K, John CC, Newton CR. Cerebral malaria: mechanisms of brain injury and strategies for improved neurocognitive outcome. Pediatr Res. 2010; 68(4):267-74. PubMed Central PMCID: PMC3056312. https://doi.org/10.1203/00006450-201011001-00524PMID: 20606600.
4. Grau GE, Craig AG. Cerebral malaria pathogenesis: revisiting parasite and host contributions. Future Microbiol. 2012; 7(2):291-302. https://doi.org/10.2217/fmb.11.155 PMID: 22324996.
5. Taylor TE, Fu WJ, Carr RA, Whitten RO, Mueller JG, Fosiko NG, et al. Differentiating the pathologies of cerebral malaria by postmortem parasite counts. Nature medicine. 2004; 10(2):143-5. https://doi.org/10.1038/nm986 PMID: 14745442.
6. Pappa V, Seydel K, Gupta S, Feintuch CM, Potchen MJ, Kampondeni S, et al. Lipid metabolites of the phospholipase A 2 pathway and inflammatory cytokines are associated with brain volume in paediatric cerebral malaria. Malaria journal. 2015; 14(1):1.
7. Evans AM, DeHaven CD, Barrett T, Mitchell M, Milgram E. Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Analytical chemistry. 2009; 81(16):6656-67. https://doi.org/10.1021/ac901536h PMID: 19624122.
8. Romisch-Margl W, Prehn C, Bogumil R, Rohring C, Suhre K, Adamski J. Procedure for tissue sample preparation and metabolite extraction for high-Throughput targeted metabolomics. Metabolomics. 2012; 8(1):133-42.
9. Reich M, Liefeld T, Gould J, Lerner J, Tamayo P, Mesirov JP. GenePattern 2.0. Nature genetics. 2006; 38(5):500-1. https://doi.org/10.1038/ng0506-500 PMID: 16642009.
10. Chyan Y-J, Poeggeler B, Omar RA, Chain DG, Frangione B, Ghiso J, et al. Potent neuroprotective properties against the Alzheimer β-amyloid by an endogenous melatonin-related indole structure, indole-3- propionic acid. Journal of Biological Chemistry. 1999; 274(31):21937-42. PMID: 10419516.
11. Morita T, Matsuyama Y, Fujimoto T, Higuchi M, Tsujii T, Matsuoka Y. Clinical significance of serum bile acid measurement in liver diseases. Gastroenterologia Japonica. 1978; 13(6):491-502. PMID: 748093.
12. Sherman IW. Biochemistry of Plasmodium (malarial parasites). Microbiological reviews. 1979; 43 (4):453-95. PubMed Central PMCID: PMC281489. PMID: 94424.
13. Papetti L, Parisi P, Leuzzi V, Nardecchia F, Nicita F, Ursitti F, et al. Metabolic epilepsy: An update. Brain Dev. 2013; 35(9):827-41. https://doi.org/10.1016/j.braindev.2012.11.010 PMID: 23273990.
14. Schwarcz R. The kynurenine pathway of tryptophan degradation as a drug target. Current opinion in pharmacology. 2004; 4(1):12-7. Epub 2004/03/17. https://doi.org/10.1016/j.coph.2003.10.006PMID: 15018833.
15. Lopansri BK, Anstey NM, Stoddard GJ, Mwaikambo ED, Boutlis CS, Tjitra E, et al. Elevated plasma phenylalanine in severe malaria and implications for pathophysiology of neurological complications. Infection and immunity. 2006; 74(6):3355-9. https://doi.org/10.1128/IAI.02106-05 PMID: 16714564.
16. Waisbren SE, Noel K, Fahrbach K, Cella C, Frame D, Dorenbaum A, et al. Phenylalanine blood levels and clinical outcomes in phenylketonuria: A systematic literature review and meta-analysis. Molecular genetics and metabolism. 2007; 92(1-2):63-70. https://doi.org/10.1016/j.ymgme.2007.05.006 PMID: 17591452.
17. Patel M. Mitochondrial dysfunction and oxidative stress: cause and consequence of epileptic seizures. Free Radic Biol Med. 2004; 37(12):1951-62. https://doi.org/10.1016/j.freeradbiomed.2004.08.021 PMID: 15544915.
18. Hwang IK, Yoo KY, Li H, Park OK, Lee CH, Choi JH, et al. Indole-3-propionic acid attenuates neuronal damage and oxidative stress in the ischemic hippocampus. Journal of neuroscience research. 2009; 87 (9):2126-37. https://doi.org/10.1002/jnr.22030 PMID: 19235887.
19. Spittler A, Winkler S, Gotzinger P, Oehler R, Willheim M, Tempfer C, et al. Influence of glutamine on the phenotype and function of human monocytes. Blood. 1995; 86(4):1564-9. PMID: 7632965.
20. Gordon EB, Hart GT, Tran TM, Waisberg M, Akkaya M, Kim AS, et al. Targeting glutamine metabolism rescues mice from late-stage cerebral malaria. Proc Natl Acad Sci U S A. 2015; 112(42):13075-80. PubMed Central PMCID: PMC4620853. https://doi.org/10.1073/pnas.1516544112 PMID: 26438846.
21. Hofmann AF, Hagey LR. Key discoveries in bile acid chemistry and biology and their clinical applications: history of the last eight decades. Journal of lipid research. 2014; 55(8):1553-95. https://doi.org/10.1194/jlr.R049437 PMID: 24838141.
22. Maggiore G, Bernard O, Hadchouel M, Lemonnier A, Alagille D. Diagnostic Value of Serum [gamma]- Glutamyl Transpeptidase Activity in Liver Diseases in Children. Journal of pediatric gastroenterology and nutrition. 1991; 12(1):21-6. PMID: 1676410.
23. Li T, Chiang JY. Bile acid signaling in metabolic disease and drug therapy. Pharmacol Rev. 2014; 66 (4):948-83. PubMed Central PMCID: PMC4180336. https://doi.org/10.1124/pr.113.008201 PMID: 25073467.
24. Whitten R, Milner DA Jr., Yeh MM, Kamiza S, Molyneux ME, Taylor TE. Liver pathology in Malawian children with fatal encephalopathy. Human pathology. 2011; 42(9):1230-9. Epub 2011/03/15. PubMed Central PMCID: PMCPmc3137725. https://doi.org/10.1016/j.humpath.2010.11.019 PMID: 21396681.
25. Greenwood J, Adu J, Davey AJ, Abbott NJ, Bradbury MW. The effect of bile salts on the permeability and ultrastructure of the perfused, energy-depleted, rat blood-brain barrier. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism. 1991; 11(4):644-54. Epub 1991/07/01.
26. Palmela I, Correia L, Silva RF, Sasaki H, Kim KS, Brites D, et al. Hydrophilic bile acids protect human blood-brain barrier endothelial cells from disruption by unconjugated bilirubin: An in vitro study. Front Neurosci. 2015; 9:80. PubMed Central PMCID: PMC4358072. https://doi.org/10.3389/fnins.2015.00080 PMID: 25821432.
27. Keene CD, Rodrigues CM, Eich T, Chhabra MS, Steer CJ, Low WC. Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington's disease. Proc Natl Acad Sci U S A. 2002; 99(16):10671-6. PubMed Central PMCID: PMC125009. https://doi.org/10.1073/pnas.162362299 PMID: 12149470.
28. Mitchell G, Kassovska-Bratinova S, Boukaftane Y, Robert M, Wang S, Ashmarina L, et al. Medical aspects of ketone body metabolism. Clinical and investigative medicine Medecine clinique et experimentale. 1995; 18(3):193-216. PMID: 7554586.
29. Cawthorn WP, Sethi JK. TNF-α and adipocyte biology. FEBS letters. 2008; 582(1):117-31. https://doi.org/10.1016/j.febslet.2007.11.051 PMID: 18037376.
30. Itoe MA, Sampaio JL, Cabal GG, Real E, Zuzarte-Luis V, March S, et al. Host cell phosphatidylcholine is a key mediator of malaria parasite survival during liver stage infection. Cell host & microbe. 2014; 16 (6):778-86. PubMed Central PMCID: PMC4271766.
31. Ghosh S, Sengupta A, Sharma S, Sonawat HM. Early prediction of cerebral malaria by 1 H NMR based metabolomics. Malaria Journal. 2016; 15(1):1.
32. Sherman IW. Amino acid metabolism and protein synthesis in malarial parasites. Bulletin of the World Health Organization. 1977; 55(2-3):265-76. PubMed Central PMCID: PMC2366754. PMID: 338183.
33. Yeo TW, Lampah DA, Gitawati R, Tjitra E, Kenangalem E, McNeil YR, et al. Impaired nitric oxide bioavailability and L-arginine reversible endothelial dysfunction in adults with falciparum malaria. The Journal of experimental medicine. 2007; 204(11):2693-704. Epub 2007/10/24. PubMed Central PMCID: PMCPmc2118490. https://doi.org/10.1084/jem.20070819PMID: 17954570.
34. Sibal L, Agarwal SC, Home PD, Boger RH. The role of asymmetric dimethylarginine (ADMA) in endothelial dysfunction and cardiovascular disease. Current cardiology reviews. 2010; 6(2):82. https://doi.org/10.2174/157340310791162659 PMID: 21532773.
35. Mickiewicz B, Vogel HJ, Wong HR, Winston BW. Metabolomics as a novel approach for early diagnosis of pediatric septic shock and its mortality. American journal of respiratory and critical care medicine. 2013; 187(9):967-76. https://doi.org/10.1164/rccm.201209-1726OC PMID: 23471468.
36. Langley RJ, Tsalik EL, van Velkinburgh JC, Glickman SW, Rice BJ, Wang C, et al. An integrated clinico- metabolomic model improves prediction of death in sepsis. Science translational medicine. 2013; 5 (195):19595-95. https://doi.org/10.1126/scitranslmed.3005893 PMID: 23884467.
37. Rogers AJ, McGeachie M, Baron RM, Gazourian L, Haspel JA, Nakahira K, et al. Metabolomic derangements are associated with mortality in critically ill adult patients. PloS one. 2014; 9(1):e87538. https://doi.org/10.1371/journal.pone.0087538 PMID: 24498130.
38. Davis JS, Darcy CJ, Yeo TW, Jones C, McNeil YR, Stephens DP, et al. Asymmetric dimethylarginine, endothelial nitric oxide bioavailability and mortality in sepsis. PloS one. 2011; 6(2):e17260. https://doi.org/10.1371/journal.pone.0017260 PMID: 21364995.
39. Yeo TW, Lampah DA, Tjitra E, Gitawati R, Darcy CJ, Jones C, et al. Increased asymmetric dimethylarginine in severe falciparum malaria: Association with impaired nitric oxide bioavailability and fatal outcome. PLoS pathogens. 2010; 6(4):e1000868. https://doi.org/10.1371/journal.ppat.1000868 PMID: 20421938.
40. Enwonwu C, Afolabi B, Salako L, Idigbe E, Bashirelahi N. Increased plasma levels of histidine and histamine in falciparum malaria: relevance to severity of infection. Journal of neural transmission. 2000; 107 (11):1273-87. https://doi.org/10.1007/s007020070017 PMID: 11145003.
41. Beghdadi W, Porcherie A, Schneider BS, Morisset S, Dubayle D, Peronet R, et al. Histamine H3 receptor- mediated signaling protects mice from cerebral malaria. PLoS One. 2009; 4(6):e6004. https://doi.org/10.1371/journal.pone.0006004 PMID: 19547708.
42. Lakshmanan V, Rhee KY, Wang W, Yu Y, Khafizov K, Fiser A, et al. Metabolomic analysis of patient plasma yields evidence of plant-like α-linolenic acid metabolism in Plasmodium falciparum. Journal of Infectious Diseases. 2012; 206(2):238-48. https://doi.org/10.1093/infdis/jis339 PMID: 22566569.